Wednesday, June 10, 2026

pharma Β· Rheumatoid Arthritis Β· Multiple Myeloma

Centocor

Centocor patent portfolio β€” 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Malvern, USA HQ
1979 Founded
568 Employees
EMA registrant Type
Company details
Status
Public
HQ
Malvern, USA
Founded
1979
Employees
568
Programs
2
Drugs
4
Patents
1
Intelligence Β· Patents

Centocor patents

1 pharmaceutical patents indexed for Centocor. 0 expire within 24 months.

Centocor has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. WO 2008137828

    MODÈLE DE MARQUEUR DE MATRICE ET PROCΓ‰DΓ‰S POUR Γ‰VALUER ET TRAITER L'ARTHRITE ET DES TROUBLES ASSOCIΓ‰S

    Expires Wed Nov 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Centocor have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Centocor patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.